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The majority of bioengineering strate-
gies use materials with isotropic cell 
distribution to produce homogenous 
tissue structures. These engineered tis-
sues, however, generally lack the micro-
scale cellular organization necessary 
for coordinated mechanical function, 
biological maturation, and in vivo inte-
gration.[1] Bioprinting offers promise for 
the assembly of 3D cell networks, how-
ever, fabrication of detailed physiological 
architectures is currently limited by reso-
lution (≈180 µm).[2] Alternatively, mate-
rial cues can be used to generate aligned 
structures at single cell resolution, how-
ever, each different pattern requires a 
new mask, mold, or scaffold.[3–5] Many 
of these limitations can be addressed 
by acoustic manipulation, whereby cells 
are translated toward the static pressure 
nodes of ultrasound standing waves.[6] 
Compared to bioprinting or material 
cues, acoustic patterning offers simpler 
Tissue engineering has offered unique opportunities for disease modeling and 
regenerative medicine; however, the success of these strategies is dependent 
on faithful reproduction of native cellular organization. Here, it is reported that 
ultrasound standing waves can be used to organize myoblast populations in 
material systems for the engineering of aligned muscle tissue constructs. Pat-
terned muscle engineered using type I collagen hydrogels exhibits significant 
anisotropy in tensile strength, and under mechanical constraint, produced 
microscale alignment on a cell and fiber level. Moreover, acoustic patterning of 
myoblasts in gelatin methacryloyl hydrogels significantly enhances myofibrillo-
genesis and promotes the formation of muscle fibers containing aligned bun-
dles of myotubes, with a width of 120–150 µm and a spacing of 180–220 µm. 
The ability to remotely pattern fibers of aligned myotubes without any material 
cues or complex fabrication procedures represents a significant advance in 
the field of muscle tissue engineering. In general, these results are the first 
instance of engineered cell fibers formed from the differentiation of acousti-
cally patterned cells. It is anticipated that this versatile methodology can be 
applied to many complex tissue morphologies, with broader relevance for 
spatially organized cell cultures, organoid development, and bioelectronics.
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fabrication, intermediate feature resolution (≈2–3 cells), and 
comparable speed (<10 min). Moreover, acoustic patterning 
enables remote and dynamic manipulation of cell popula-
tions within biomaterials, while complex, nonlinear archi-
tectures can be generated using hologram-based acoustics.[7] 
To date, 2D and 3D acoustic cell patterning has been used 
to study biological processes such as neurite guidance,[8] 
angiogenesis,[9] neural differentiation,[10] and cardiomyocyte 
beating.[11,12] Here, we use ultrasound standing waves to 
direct the assembly of myoblasts in collagen-based hydrogels, 
and then stimulate these patterned materials to undergo in 
situ myogenesis and engineer bundles of aligned myotubes 
(Figure 1A). This approach, which also resulted in significant 
M. K. Nichols
Centre for Organized Matter Chemistry and Centre for Protolife Research
School of Chemistry
University of Bristol
Bristol BS8 1TS, UK
Dr. A. W. Perriman
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University of Bristol
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tensile anisotropy and enhanced myofibrillogenesis, offers 
a new platform for the engineering of anisotropic tissue 
morphologies.
We designed an acoustic patterning device possessing 
features compatible with both ultrasound generation and sterile 
cell culture. We fabricated an acrylic plate with a central cavity to 
house a 35 mm petri dish containing a suspension of cells. This 
cavity was flanked by four lead zirconate titanate piezotrans-
ducers, which were driven at their resonant frequencies to pat-
tern arrays of C2C12 myoblasts (Figure 1B,C and Figures S1 
and S2, Supporting Information). The cell arrays correlated 
closely with theoretical models and direct empirical measure-
ments of the pressure field, evidence that cells had translated 
to the nodal planes (Figure S3, Supporting Information). The 
patterning of myoblasts in cell medium was visualized using 
confocal fluorescence microscopy, analyzed using a Hough 
transform pattern recognition algorithm and quantified using 
a unidirectional patterning index (S) calculated from a fast 
Fourier transform (FFT) (Figure S4, Supporting Information). 
These analyses revealed a rapid transition from an unordered 
population with no identifiable features (S = 14 ± 5%) to a peri-
odic array of parallel features (S > 90%) in just 30 s. Further-
more, we demonstrated that in situ frequency transitions 
Adv. Mater. 2018, 30, 1802649
Figure 1. Acoustic cell patterning. a) The acoustic radiation force (F) can translate cells toward the pressure nodes of ultrasound standing waves. 
Controlled gelation processes can be used to pattern cells into materials for tissue engineering. b) The acoustic patterning device, with two pairs of 
piezotransducers used to generate ultrasound standing waves across a petri dish of cells. c) Wide-field fluorescence microscopy of myoblasts (green) at 
6 × 105 cells mL−1 patterned in suspension. Scale bars, 200 µm. d) Time-lapse microscopy images of myoblasts (yellow) in suspension, first patterned 
at 6.7 MHz and then switched to a 2.0 MHz field at 3.5 s. Scale bars, 200 µm. e) An alamarBlue assay performed on unexposed myoblasts (gray) or 
myoblasts exposed for 30 min to 2.0–2.1 MHz ultrasound (red) showed no significant difference in metabolic activity, immediately after exposure or 
after 1 d of culture. Data shown as mean ± standard deviation, n = 5 from five paired exposure experiments, ns = nonsignificant (two-tailed Wilcoxon 
matched pairs test).
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could be used to dynamically reconfigure patterned cell arrays 
(Figure 1D).
We tested the compatibility of acoustic patterning for 
muscle engineering by exposing myoblasts suspended in 
cell medium to a 2.0–2.1 MHz field for 30 min. This expo-
sure produced no significant detrimental effects upon cell 
metabolic activity (alamarBlue assay; 0, 1 d), cell prolifera-
tion (PicoGreen DNA assay; 1–2 d), myogenic gene expres-
sion (MYOG, MRF4; 2–8 d), or muscle protein expression 
(α-myosin skeletal fast; 7 d) (Figure 1E and Figures S5 and S6, 
Supporting Information). We also showed that these field 
parameters could be used to pattern myoblasts within a range 
of hydrogels, including agarose, Matrigel, and poly(ethylene 
glycol) (PEG) norbornene (Figure S7, Supporting Information). 
However, the material we first selected for muscle engineering 
was type I collagen; a major component of skeletal muscle[13] 
and an established system for myoblast adhesion, survival, 
and differentiation.[14] Neutralizing acidified collagen initi-
ated a slow gelation process that we used to encapsulate a thin 
layer (2–3 cells) of acoustically patterned myoblasts at different 
material concentrations (1–5 mg mL−1) and seeding densities 
(1–10 × 106 cells mL−1) (Figure S8, Supporting Information).
For muscle tissue engineering, we used 3 mg mL−1 collagen 
with a 30 min exposure to an ultrasound standing wave of 
0.12 ± 0.2 MPa pressure amplitude to ensure well-defined pat-
terning, and 3 × 106 myoblasts with a 2.0–2.1 MHz frequency 
to provide a cell fiber width (≈60–80 µm) that mimicked physi-
ological tissue (40–100 µm).[15] After gelation, the patterned 
hydrogels were removed from the field, cultured for 1 d, and 
then differentiated in myogenic medium for muscle tissue 
engineering. The collagen effectively maintained the via-
bility of the cells as they shifted from a rounded morphology 
(t = 0 d) into adherent myoblasts (t > 1 d) (Figure 2A). Over 
time, the myoblasts contracted the surrounding matrix yet the 
patterned configuration was retained throughout. We imaged 
this process using time-lapse microscopy and measured 
a steady reduction in peak-to-peak fiber separation from 
380 ± 19 to 190 ± 12 µm over 24 h (Figure S9, Supporting 
Information). Even at day 4, however, the space between adja-
cent fibers (≈50–70 µm) was still greater than the close-packed 
fibers in native muscle.[15] We exploited the tissue contraction 
by clamping the patterned collagen during tissue engineering 
to restrict contraction longitudinally and produce a static load 
in the direction of the myoblast fibers (Figure 2B,C). These 
Adv. Mater. 2018, 30, 1802649
Figure 2. Engineering patterned muscle using collagen. a) Bright-field and confocal fluorescence microscopy of acoustically patterned myoblasts in 
3 mg mL−1 collagen. 4 mm diameter biopsy sections, isolated over 4 d, were stained with calcein (green, viable cells) and ethidium homodimer 
(red, nonviable cells). Bright-field scale bars, 0.5 mm. Fluorescence scale bars, 200 µm. b) Schematic of mechanical clamping showing how imposed 
boundary conditions were used to generate static tensile load (red arrow) parallel with the patterned myoblast lines. c) Confocal fluorescence micro-
scopy of the clamped constructs revealed cell-level orientation and reduced interfiber contraction. Scale bars, 200 µm. d) Mechanical testing was 
performed with tensile strain applied either orthogonal or parallel with the cell lines. e) The tensile Young’s modulus for the orthogonal and parallel 
configurations. Paired data from seven separate tissues (one-tailed Wilcoxon matched pairs test), p ≤ 0.01 (**).
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conditions enabled us to engineer tissues with cells individu-
ally oriented within the acoustically patterned fibers. This 
hierarchical structure could not be achieved through clamping 
alone, with clamped unpatterned tissues exhibiting cell ori-
entation but no bulk organization (Figure S10, Supporting 
Information).
We evaluated the mechanical anisotropy of the acoustically 
patterned, unclamped constructs after 1 d in culture, using 
quasi-static tensile loading with strain applied either parallel 
or orthogonal to the patterned cell lines (Figure 2D,E). We 
measured an 80% increase in tensile Young’s modulus for 
the parallel configuration (E|| = 13.4 ± 9.6 kPa) compared to 
the orthogonal setup (E◻ = 7.4 ± 5.0 kPa), the first example in 
which acoustic patterning has been used to engineer mechan-
ical anisotropy into a cellularized biomaterial. We attributed 
the tensile anisotropy to the aligned intercellular interactions 
spanning the length of the construct; for reference, the detach-
ment force required to separate a pair of myoblasts is ≈12 nN 
after just 10 min of adhesion.[16] We next evaluated the differ-
entiation state of the tissue after 4 d using quantitative poly-
merase chain reaction (qPCR) and immunostaining, in which 
we observed upregulation of myogenic regulatory factors 
(MYOG, MRF4) and positive staining for contractile proteins 
(α-myosin skeletal fast, tropomyosin) (Figure S11, Supporting 
Information).
Although collagen supported the culture and differentia-
tion of patterned myoblasts, the matrix contraction made it 
challenging to assess the long-term processes of myotube for-
mation and tissue maturation. Accordingly, we investigated 
whether aligned muscle could be engineered using gelatin 
methacryloyl (GelMA) instead of collagen. We methacrylated 
≈88 ± 1% of the lysine residues of gelatin (Figure S12, 
Supporting Information) to produce GelMA solutions that 
could be covalently crosslinked in the presence of photoini-
tiator and ultraviolet light.[17] We were able to pattern myo-
blasts in 40 mg mL−1 GelMA, the optimal weight fraction for 
myofibrillogenesis,[18] using similar field parameters as for 
collagen (2.0–2.1 MHz, 12 min). Importantly, the covalent link-
ages, high weight fraction, and amorphous structure of GelMA 
ensured that the engineered tissue maintained its original size 
and interfiber separation distance (Figure 3A). These factors 
enabled unhindered observation of the latter stages of tissue 
development, most notably, the formation of elongated myo-
tubes at 7 d. These myotubes were viable, present throughout 
the tissue and generally confined to the original myoblast 
pattern. Interestingly, the unpatterned controls exhibited 
negligible myotube formation (Figure S13, Supporting Infor-
mation), suggesting that acoustic patterning had facilitated 
myofibrillogenesis. Having already ascertained that field expo-
sure does not affect myotube formation, this enhancement 
was attributed to the increased cell–cell contact conferred by 
patterning.
qPCR revealed significantly upregulated expression of 
MYOG and MRF4 for the day 7 patterned tissue, compared to 
Adv. Mater. 2018, 30, 1802649
Figure 3. Engineering patterned muscle using GelMA. a) Confocal fluorescence microscopy of acoustically patterned myoblasts in 40 mg mL−1 GelMA 
over 7 d of tissue engineering. Myoblasts were stained with calcein (green, viable cells) and ethidium homodimer (red, nonviable cells). Scale bars, 
200 µm. b) Relative expression of MYOG and MRF4 in the unpatterned (gray) and patterned (red) tissues at day 7, compared to undifferentiated 
myoblasts. Data shown as mean ± standard deviation from five tissues (two-tailed Mann–Whitney test), p ≤ 0.01 (**). c) Immunostaining for α-myosin 
skeletal fast and tropomyosin (both red) counterstained with 4′,6-diamidino-2-phenylindole (DAPI, blue, nucleus) in the patterned tissue at day 7. 
Low-magnification scale bars, 300 µm. High-magnification (z-projection over 54 µm) scale bar, 100 µm. d) Myotube length as a function of orientation 
angle showing that the majority of myotubes were oriented within 20° of the acoustically patterned lines.
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undifferentiated myoblasts (Figure 3B). We observed no signifi-
cant difference between unpatterned and patterned muscle in 
the expression of MYOG, which is thought to regulate the early 
stages of myogenesis.[19] The patterned tissue did exhibit an 
eightfold higher expression of MRF4, believed to play a critical 
role in myotube maturation,[19] which corroborates the theory 
that patterning had facilitated myofibrillogenesis. Finally, 
immunostaining revealed widespread expression of α-myosin 
skeletal fast and tropomyosin, with stained myotubes observed 
predominantly within the acoustically patterned template 
(Figure 3C). This spatial confinement appeared to direct myo-
blast fusion, with the majority of myotubes (>70%) oriented 
within 20° of the acoustically patterned fibers (Figure 3D). 
Moreover, the oriented myotubes were generally of greater 
length (0.37 ± 0.14 mm) than the small fraction of orthogonally 
branching myotubes (0.29 ± 0.12 mm). Finally, we showed that 
the acoustically patterned fibers at day 7 showed a frequency-
dependent response to pulsed electrical stimulation, evidence 
of functional patterned myotubes (Figure S14 and Video S1, 
Supporting Information).
These results demonstrate, for the first time, that aligned cel-
lular fibers can be engineered from a material system bearing 
acoustically patterned cells. We show that a brief application 
of ultrasound standing waves (<30 min, 2.0–2.1 MHz) can be 
used to pattern myoblasts in collagen-based hydrogels for the 
engineering of muscle tissue with dense, aligned fibers. This 
strategy offers great flexibility across different bioengineering 
protocols, addressing several key limitations facing in vitro 
muscle formation. Myoblasts patterned in collagen contracted 
the surrounding matrix to produce high-density muscle fibers 
and anisotropic tensile mechanics. By clamping the patterned 
collagen we could generate, to the best of our knowledge, the 
first instance of an in vitro engineered tissue exhibiting cell 
alignment on both an individual cell and population-wide level. 
We used a third protocol, with myoblasts patterned in GelMA 
hydrogels, to significantly enhance myofibrillogenesis and 
produce tissue constructs with oriented multinucleated myo-
tubes bundled into parallel, aligned muscle fibers. The engi-
neered fiber width (≈120–150 µm) is larger than native tissue 
(≈40–100 µm)[15] but comparable to structures formed from 
micropatterned hydrogels (≈50–330 µm).[3,4] Overall, we have 
demonstrated that acoustic patterning can be used to recreate 
the microscale hierarchical alignment of bundled myotubes 
without the need for material cues. Future work will focus on 
macroscale organization, potentially by integrating a vertical 
standing wave to levitate myoblasts for the assembly of 3D, 
close-packed fibers.
Experimental Section
Acoustic Cell Patterning: All reagents from Thermo Fisher Scientific, 
unless otherwise stated. A 20 Vpp driving voltage was supplied by a 
TG120 20 MHz Function Generator (Aim TTi) to piezotransducers with 
wrap-around electrodes (NCE51, Noliac) integrated into the patterning 
device (see Figure S1, Supporting Information). The impedance was 
characterized using a TE1000 RF Vector Impedance Analyser (Tomco 
Technologies). The pressure field was measured using a Fibre-Optic 
Hydrophone (Precision Acoustics Ltd.) mounted on a motorized 
stage, with the output voltage sampled at 100 MHz. The amplitude 
at 2.0–2.2 MHz was measured (3 × 3 mm, 50 µm pixel size) and 
the probe calibration was used to calculate the pressure amplitude 
(0.12 ± 0.02 MPa). Pressure-field modeling was performed using the 
Huygens wave theory and the dimensions of the acoustic patterning 
device. C2C12 myoblasts (ATCC) or RFP/GFP-expressing C2C12 
myoblasts expanded in high glucose Dulbecco’s modified Eagle’s 
medium (HG-DMEM) with 1% (v/v) penicillin/streptomycin and 20% 
(v/v) fetal bovine serum, were acoustically patterned in 35 mm Petri 
dishes coated with 2 mL autoclaved 2% (w/v) UltraPure Agarose 1000. 
Patterning protocols were adapted for each experiment: (1) Myoblasts 
were patterned for 30 min in 1 mL of neutralized 3 mg mL−1 type I 
collagen in a tissue culture incubator. Collagen extraction, gelation, and 
clamping were based on published protocols.[20] For clamped tissue 
culture, 10 × 35 mm strips of hydrogel, with the patterned lines oriented 
lengthwise, were secured on a machined platform using stainless steel 
clamps. (2) Myoblasts were patterned for 12 min in 1 mL of 40 mg mL−1 
GelMA dissolved in sterile-filtered 5 mg mL−1 Irgacure 2959 (Sigma) 
in PBS at 37 °C on a Polar Bear Plus hot plate (Cambridge Reactor 
Design). Ultraviolet irradiation (365 nm, 6 mW cm−2) was applied for 
the final 2 min before washing the hydrogel (2 mL of PBS, then 3 × 2 mL 
HG-DMEM). GelMA was synthesized using published protocols[17] and 
characterized using an Avance 600 MHz spectrometer (Bruker) and a 
(2,4,6-trinitrobenzene sulfonic acid) assay (Sigma). (3) RFP-myoblasts 
were patterned for 10 min in 25% (v/v) Matrigel Matrix (Corning) on ice, 
followed by 5 min gelation at 37 °C. (4) RFP-myoblasts were patterned 
for 10 min in 0.5% (w/v) ultralow gelling temperature agarose (Sigma) 
at 37 °C, followed by 30 min gelation at 25 °C. (5) RFP-myoblasts were 
patterned for 2 min in 8% (w/v) 20 kDa eight-arm PEG norbornene 
(synthesized using established protocols),[21] 13.25 mg mL−1 1 kDa 
PEG dithiol (Sigma), and 0.54 mg mL−1 Irgacure 2959, followed by 
7 min ultraviolet irradiation (365 nm, 6 mW cm−2). (6) Calcein-stained 
myoblasts were patterned for 5–10 min in 2 mL of expansion medium 
with 20 × 10−3 m HEPES buffer.
Tissue Engineering and Analysis: Collagen and GelMA constructs, 
including clamped hydrogels, were maintained in expansion medium 
for 1 d, then differentiated in HG-DMEM with 1% (v/v) penicillin/
streptomycin, 1% (v/v) non-essential amino acids, 1% (v/v) N-2, and 
20 ng µL−1 recombinant human IGF-1 (PeproTech). Eight analyses 
were performed: (1) Tensile testing. A 0.1% strain s−1 was applied to 
rectangular tissue biopsies using a 250 g load cell on an Electroforce 
5100 (BOSE), with Young’s modulus calculated at 0.05–0.15 strain. (2) 
Immunostaining. Tissues were fixed for 10 min in 4% (v/v) formaldehyde 
(Sigma), permeabilized for 10 min in 0.5% (v/v) triton X-100 (Sigma) at 
4 °C, blocked overnight in 3% (w/v) bovine serum albumin (BSA, Sigma) 
in PBS, incubated overnight at 4 °C with 1:4000 anti-myosin skeletal 
fast (Sigma) or 1:50 anti-tropomyosin (Sigma) in 3% BSA/PBS, washed 
(3 × 5 min 3% BSA/PBS), stained for 2 h with 1:750 anti-mouse Alexa 
Fluor 555 in 3% BSA/PBS, washed (3 × 5 min 3% BSA/PBS) and then 
counterstained for 10 min with DAPI (Sigma). Confocal fluorescence 
microscopy was used for imaging, with end-to-end line measurements of 
myotubes in GelMA made using FIJI. (3) Gene expression. Tissues were 
freeze-thawed at −80 °C with 600 µL TRIzol before mechanical disruption 
with a TissueLyser II (Qiagen) for 5 min at 15 s−1. A chloroform 
extraction and Direct-zol RNA Miniprep Kit (Cambridge Bioscience) were 
used to extract RNA (260:280 > 1.6). A QuantiTect Reverse Transcription 
Kit (Qiagen) was used to synthesize cDNA (assuming 1:1 conversion). 
Taqman Probes (CSNK2A2, AP3D1, MYOG, MRF4) and a StepOnePlus 
Real Time PCR System were used to measure relative expression 
(ΔΔCT) using CSNK2A2 and AP3D1 as endogenous controls. (4) Single 
timepoint imaging. 4 mm diameter biopsies were isolated at intervals, 
stained using a LIVE/DEAD kit and imaged using confocal fluorescence 
microscopy. (5) Contraction imaging. Collagen hydrogels patterned 
with GFP-myoblasts were imaged in culture using time-lapse wide-
field microscopy, with profile plots and separation distances measured 
at 4 h intervals using FIJI. (6) Electrical pacing. Patterned GelMA 
tissues at day 7 were stained with fluo-4 AM dye (Invitrogen) and point 
stimulated in Tyrode’s solution (10 × 10−3 m NaCl, 4.5 × 10−3 m KCl, 
10 × 10−3 m glucose, 10 × 10−3 m HEPES, 1 × 10−3 m MgCl2, 1.8 × 10−3 m 
CaCl2, pH 7.4) at 37 °C using a MyoPacer Field Stimulator (IonOptix, 
Adv. Mater. 2018, 30, 1802649
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20 ms, 40 ± 10 V, 1–4 Hz). Time-lapse images were captured using 
wide-field microscopy (250 fps) and analyzed using MUSCLEMOTION 
(Open Source).[22] (7) Patterning imaging. Calcein-stained myoblasts 
suspended in expansion medium with 20 × 10−3 m HEPES were imaged 
using time-lapse confocal fluorescent microscopy, with patterning 
initiated after 5 s. FIJI and MATLAB R2016b (MathWorks) were used to 
perform Hough transform, FFT, and time-resolved FFT. (8) Myoblasts 
patterned in Matrigel, agarose, PEG norbornene, and expansion medium 
were imaged using wide-field microscopy.
Field Exposure Studies: 5–6 × 106 myoblasts in expansion medium 
were exposed to a 2.0–2.1 MHz field for 30 min, with gentle pipetting 
every 10 min to disrupt the formation of cellular aggregates. An identical 
setup but without field exposure was used as an unexposed control for 
four experiments. (1) An alamarBlue assay was performed immediately 
after field exposure and after 1 d of culture, (2) A Quant-iT PicoGreen 
dsDNA Assay was performed after 1 and 2 d of culture, (3) qPCR was 
performed after 3 d of culture and 2, 4, and 8 d of differentiation, and 
(4) immunostaining was performed after 3 d of culture and 7 d of 
differentiation.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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